Biomarkers of Cognitive Impairment: Brain Cortical Thickness, Volumetrics, and Cerebrospinal Fluid

Authors

Ladan Ghazi-Saidi, University of Nebraska at Kearney
Ryan R. Walsh, Barrow Neurological InstituteFollow
Guogen Shan, University of Nevada, Las VegasFollow
Sarah J. Banks, Cleveland Clinic Lou Ruvo Center for Brain Health

Document Type

Article

Publication Date

1-1-2018

Publication Title

Alzheimer Disease & Associated Disorders

Volume

32

Issue

3

First page number:

255

Last page number:

257

Abstract

Brain changes realted to Alzeimer's disease (AD) exist years before manifestation of any cognitive decline. Mild cognitive impairment (MCI) is impairment in cognition with preserved independence and functional abilities. MCI is considered a risk factor for dementia, however, not all MCI conditions are due to AD pathology.

Keywords

Alzheimer's disease, Biomarkers, Cortical thickness, Volumetric, CSF

Language

eng

Repository Citation

Ghazi-Saidi, L., Walsh, R. R., Shan, G., Banks, S. J. (2018). Biomarkers of Cognitive Impairment: Brain Cortical Thickness, Volumetrics, and Cerebrospinal Fluid. Alzheimer Disease & Associated Disorders, 32(3), 255-257.
http://dx.doi.org/10.1097/WAD.0000000000000226